Study to Assess the Efficacy and Safety of Ad26.COV2.S (the Johnson & Johnson COVID vaccine) for the Prevention of SARS-COV-2 mediated COVID-19 in Adults Aged 18 Years and Older
Closed to enrollment and study follow-up
Web Links:
Filter
Study to Assess the Efficacy and Safety of Ad26.COV2.S (the Johnson & Johnson COVID vaccine) for the Prevention of SARS-COV-2 mediated COVID-19 in Adults Aged 18 Years and Older
Closed to enrollment and study follow-up
Web Links:
Join our mailing list to receive the latest news and updates from our team.